Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Flupirtine as Oral Treatment in Multiple Sclerosis (FLORIMS)
Dimethyl Fumarate Inhibits the Nuclear Factor kappaB Pathway in Breast Cancer Cells by Covalent Modification of p65.
IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation.
Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis.
Neuroimmunology: Clostridium-reactive T cells are implicated in the pathogenesis of neuromyelitis optica.
Combination therapy in patients with relapsing-remitting multiple sclerosis (MS) CombiRx
Cost-utility of fingolimod compared with dimethyl fumarate in highly active relapsing-remitting multiple sclerosis (RRMS) in England.
Synergistic Effects of Reserve and Adaptive Personality in Multiple Sclerosis.
Dimethyl fumarate (BG-12, Tecfidera) approved for use by the NHS in Scotland
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.
Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safety.
Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders.
Long-term effectiveness of glatiramer acetate in clinical practice conditions.
Headache in relapse and remission phases of multiple sclerosis: A case-control study.
Emerging oral agents for multiple sclerosis.
Effects of fumaric acid esters on blood-brain barrier tight junction proteins.
Glatiramer acetate in combination with minocycline in patients with relapsing--remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial.
Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over four years.
[Reduction of spastic increased muscle tone in multiple sclerosis by the nonopioid analgesic flupirtine].
A Safety and Efficacy Extension Study of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (DreaMS)
Regulation of B cell function by the immunosuppressive agent leflunomide.
Genpharm and Genzyme Aubagio ® agreement for the MENA region
Synaptic pathology: a shared mechanism in neurological disease.
A map of the human neocortex showing the estimated overall myelin content of the individual architectonic areas based on the studies of Adolf Hopf.
Sex differences in comorbidity at diagnosis of multiple sclerosis: A population-based study.

Pages